Norbert Köhler

Norbert Köhler

Auto-generated profile, based on publicly available information

Norbert Köhler

Leipzig University, Faculty of Medicine, Clinical Trial Centre (ZKS Leipzig), Leipzig, Germany

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2016 in European Journal of Cancer Care
Verified
Journal Article
Closed access
PDF file
HGH. Götze
H. Götze
EBE. Brähler
E. Brähler
LGL. Gansera
L. Gansera
ASA. Schnabel
A. Schnabel
AGA. Gottschalk-Fleischer
A. Gottschalk-Fleischer
NKN. Köhler
N. Köhler

9 May 2014 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
HGHeide Götze
Heide Götze
EBElmar Brähler
Elmar Brähler
LGLutz Gansera
Lutz Gansera
NPNina Polze
Nina Polze
NKNorbert Köhler
Norbert Köhler

1 July 2019 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
JBJens Bräunlich
Jens Bräunlich
DDDominic Dellweg
Dominic Dellweg
ABAndreas Bastian
Andreas Bastian
SBStephan Budweiser
Stephan Budweiser
WRWinfried Randerath
Winfried Randerath
HWHubert Wirtz
Hubert Wirtz
Background: Despite the encouraging results of noninvasive ventilation (NIV) in chronic hypercapnic COPD patients, it is also evident that some patients do not tolerate NIV or do not benefit from it. We conducted a study in which COPD patients with stable, chronic hypercapnia were treated with NIV and nasal high-flow (NHF) to compare effectiveness. Methods: In a multi-centered, randomized, controlled, cross-over design, patients received 6 weeks of NHF ventilation followed by 6 weeks of NIV ventilation or vice-versa (TIBICO) between 2011 and 2016. COPD patients with stable daytime hypercapnia (pCO2≥50 mmHg) were recruited from 13 German centers. The primary endpoint was pCO2 changes from baseline blood gas, lung function, quality of life (QoL), the 6 min walking test, and duration of device use were secondary endpoints. Results: A total of 102 patients (mean±SD) age 65.3±9.3 years, 61% females, body mass index 23.1±4.8 kg/m,2 90% GOLD D, pCO2 56.5±5.4 mmHg were randomized. PCO2 levels decreased by 4.7% (n=94; full analysis set; 95% CI 1.8–7.5, P=0.002) using NHF and 7.1% (95% CI 4.1–10.1, P<0.001) from baseline using NIV (indistinguishable to intention-to-treat analysis). The difference of pCO2 changes between the two devices was −1.4 mmHg (95% CI −3.1–0.4, P=0.12). Both devices had positive impact on blood gases and respiratory scores (St. George’s Respiratory Questionnaire, Severe Respiratory Insufficiency Questionnaire). Conclusions: NHF may constitute an alternative to NIV in COPD patients with stable chronic hypercapnia, eg, those not tolerating or rejecting NIV with respect to pCO2 reduction and improvement in QoL.

25 July 2019 in BMC Urology
Verified
Journal Article
Open access
PDF file
SHSigrun Holze
Sigrun Holze
MMMeinhard Mende
Meinhard Mende
KHKarl V. Healy
Karl V. Healy
NKNorbert Koehler
Norbert Koehler
LGLutz Gansera
Lutz Gansera
JSJens-Uwe Stolzenburg
Jens-Uwe Stolzenburg
Due to the usage of various measurement methods and definitions, comparing continence rates after radical prostatectomy is a challenging task. This study compares continence rates based on different methods and aims to identify the definition for continence which agrees best with the patients’ subjective assessment of continence. Additionally, continence was controlled for multiple influencing factors. This prospective multicentre study was carried out in seven hospitals throughout Germany. Before and at 3, 6, and 12 months after surgery self-reporting questionnaires were completed and returned by 329 (84.4%) of 390 eligible patients. The questionnaires were independently evaluated and analysed by a third party. Association of continence with demographic, operative, and tumour factors in an ongoing comprehensive prostate cancer database was evaluated. The continence rate drops substantially for patients undergoing radical prostatectomy but increases again with time. Concrete numbers vary considerably depending on definition – 44% at 3 months and 68% at 12 months after surgery (0 pads) vs. 71 and 90% (0–1 pads). Significant confounding variables regarding continence rate are nerve-sparing procedure, categorized Gleason score, rehabilitative cure treatment, and pelvic floor training. The definition of 0 pads for continence coincides greater than 0–1 pads with the patients’ self-assessment of being continent. A standardized definition for continence would be desirable, as it is one of the most important preconditions to guarantee sound comparison of continence rates. Since there are enough other factors that make comparison difficult, we suggest using the definition of “0 pads”. It is easily measured objectively, leaves no room for interpretation, and agrees best with the patients’ self-assessment.

22 August 2019 in Health and Quality of Life Outcomes
Verified
Journal Article
Open access
PDF file
KGKristina Geue
Kristina Geue
HGHeide Götze
Heide Götze
MFMichael Friedrich
Michael Friedrich
KLKatja Leuteritz
Katja Leuteritz
AMAnja Mehnert-Theuerkauf
Anja Mehnert-Theuerkauf
NKNorbert Köhler
Norbert Köhler
This study compared the perceived social support of young and older adult cancer patients, examining possible influencing factors as well as associations with health-related quality of life. A total of 179 young patients (18–39 years) and 200 older adult patients (> 70 years) with haematological malignancies completed questionnaires on their perceived social support (ISSS-8, scales: Positive Support and Detrimental Interactions, range 0–16) and health-related quality of life (EORTC QLQ-C30). Tests for mean differences, correlations and regression analyses to determine associated variables of social support were performed. No difference was reported between young (M = 13.40, SD = 2.81) and older adult patients (M = 13.04, SD = 3.82; p = .313) for Positive Support. However, young patients (M = 4.16, SD = 3.10) reported having had more Detrimental Interactions than older patients did (M = 1.63, SD = 2.42; p < .001, Cohen’s d = .910). Comparison of the EORTC QLQ-C30 Function scales showed poorer outcomes for young patients on Emotional, Cognitive and Social Functions and a higher outcome on Physical Function compared with older adult patients. Regression analyses indicated that age (young vs. older adult patients) significantly explained proportions of variance in all models, with young age having a negative impact on Emotional, Cognitive and Social Functions and a positive impact on Physical and Role Functions compared with old age. Significant associations between Detrimental Interactions and all the scales examined except Cognitive Function were found. The difference in negative perceptions of social support in young vs. older adult patients and its impact on health-related quality of life emphasises the necessity of differentiating between positive and negative social support. Negative interactions should be addressed through psychosocial care, particularly with young cancer patients.

13 February 2014 in European Journal of Cancer Care
Verified
Journal Article
Closed access
PDF file
NKN. Köhler
N. Köhler
MFM. Friedrich
M. Friedrich
LGL. Gansera
L. Gansera
SHS. Holze
S. Holze
RTR. Thiel
R. Thiel
EBE. Brähler
E. Brähler
The aim of this prospective multi‐centre study was to evaluate the level of psychological distress (PD) and adjustment to disease in patients who underwent radical prostatectomy. Furthermore, the impact of urinary incontinence and erectile dysfunction on PD was assessed. Anxiety, depression and PD were evaluated using the Hospital Anxiety and Depression Scale in 329 prostate cancer patients before surgery as well as 3, 6 and 12 months after surgery. These results were compared with those of a male German general population reference group. Adjustment to disease was assessed using the Perceived Adjustment to Chronic Illness Scale. Patients reported low levels of PD at all points of assessment similar to population norms of age‐matched German men. Persistent PD was seen in about 8% of the patients and 20% had PD at least two of the measurement points. Relevant predictors for PD after surgery were urinary symptoms and baseline PD. Adjustment to disease was highest before surgery and had significantly reduced at 3 and 6 months after surgery. In general, men are resilient to the experience of localised prostate cancer and adjust well psychologically after surgery. However, between 8% and 20% of patients could possibly benefit from mental health support.